Abstract. TGF-/3 is a potent stimulator of motility in a variety of cell types. It has recently been shown that hyaluronan (HA) can directly promote locomotion of cells through interaction with the HA receptor RHAMM. We have investigated the role of RHAMM and HA in TGF-/3-stimulated locomotion and show that TGF-B triggers the transcription, synthesis and membrane expression of the RHAMM receptor and the secretion of HA coincident with the induction of the locomotory response. This was demonstrated by both incubating cells with exogenous TGF-Bt and by stimulating the production of bioactive TGF-/3~ in tumor cells transfected with TGF-B~ under the control of the metallothionein promoter. TGF-/31-induced locomotion was suppressed by antibodies that prevented HA/RI-IAMM interaction, using polyclonal antibodies to either RHAMM fusion protein or RHAMM peptides, or mAbs to purified RHAMM. Peptides corresponding to the HA-binding motif of RHAMM also suppressed TGF-B,-induced increases in motility rate. Spontaneous locomotion of fibrosarcoma cells was blocked by neutralizing secreted TGF-~/with panspecific TGF-/3 antibodies and by inhibition of TGF-/3~ secretion with antisense oligonucleotides. Polyclonal anti-RHAMM fusion protein antibodies and peptide from the RHAMM HA-binding motif also suppressed the spontaneous motility rate of fibrosarcoma cells. These data suggest that fibrosarcoma cell locomotion requires TGF-/3, and the pathway by which TGF-~/stimulates locomotion uses the HA receptor RHAMM and HA.
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THOUGH the factors that control cell locomotion are poorly understood, it is becoming clear that some ceils can produce autocrine motility factors and cytokines (Liotta and Schiffman, 1988; Stoker and Gberardi, 1991 ) through which they regulate chemokinesis and chemotaxis. Transforming growth factor betas (TGF-/~s)~, of which there are three manunalian isoforms, are 25-kD homodimeric peptides that act as multifunctional regulators of mesenchymal, endothelial, and epithelial cells (Roberts and Sporn, 1989; Bamard et al., 1990; Massagu6 et al., 1990) . TGF-B has been implicated in a variety of physiological and pathological processes in which cell locomotion is essential such as embryogenesis (Heine et al., 1987) , wound repair (Pierce et al., 1989) , inflammation (Allen et al., 1990; Khalil et al., 1990 Khalil et al., , 1991 , and tumor invasion (Welsh et al., 1991; McCarthy and Turley, 1992; Samuel et al., 1992) .
TGF-B1 in its role as a regulator of cell motility is a powerful chemoattractant that promotes both chemokinesis and chemotaxis in a variety of cell types (Posflethwaite et al.,
1. Abbreviations used in this paper: DM, defined medium; ECL, enhanced chemiluminescence, GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HA, hyaluronan; TGF-13, transforming growth factor beta.
1987; Wahl et al., 1987; Reibman et al., 1991; Samuel et al., 1992) . In neutrophils and maerophages, TGF-B has been observed to be a potent chemoattractant (Wahl et al., 1987; Fava et al., 1991; Riebman et al., 1991) , and it has been suggested that the chemotactic potency of TGF-B for macrophages may be relevant for diseases that are characterized by inflammation and fibrosis (Khalil and Greenberg, 1991; Fava et al., 1991) . TGF-/3 may be involved in the initial recruitment of macrophages and the migration of fibroblasts seen in these lesions. Posflethwaite and co-workers (1987) have shown that picogram levels of TGF-B1 are sufficient to enhance chemokinesis and chemotaxis of normal fibroblasts.
While the mechanism through which TGF-/3 regulates locomotion is poorly understood, studies in neutrophils indicate that TGF-/51 triggers protein synthesis and actin assembly that are required for chemotaxis but, unlike conventional ebemoattractants, it does not act via common signal transduction pathways (Riebman et al., 1991) . In many cell types, TGF-B promotes hyaluronan (HA) synthesis (Toole et al., 1989; Heldin et al., 1989) , while HA is important in fibrosarcoma cell locomotion following transformation by H-ms (Turley et al., 1991) and in mammary carcinoma cell locomotion (Schor et al., 1989) . HA is a repeating disaccharide of N-acetyl-glucosamine and o-glucuronic acid that is not sulfated, unlike other glycosaminoglycans. HA accumulates at sites of embryonic call migration (for review see Toole et al., 1989) , and coincides with the appearance of macrophages and fibroblasts in wound repair responses in the lung (Bray et al., 1991; Nettelbladt et al., 1989) . Increased synthesis of HA is seen in melanoma and carcinoma cell lines both in vivo and in vitro, and HA synthesis correlates with increased invasiveness and metastatic ability of these tumors (Turley and Tretiak, 1985; Kimata et al., 1983; Toole et al., 1979) . HA can directly promote locomotion and accumulates in the extending lamellae of motile cells (Turley et al., 1991) . Several HA binding proteins have been identified but only two cell membrane receptors, CD44 and RHAMM, have been cloned (for reviews see Toole, 1990; Turley, 1991) . Recently, we have shown that the production of RHAMM and HA is required for tumor cell locomotion (Hardwick et al., 1992) . RHAMM, a 58-kD glycoprotein, is a novel HA receptor that bears no primary sequence homology to other known HA-binding proteins. RHAMM accumulates at the tips of advancing lamellipodia in locomoting cells and polyclonal antibodies directed to peptides of the deduced amino acid sequence block HA-stimulated locomotion (Hardwick et al., 1992) . In the present study, we have examined the mechanism by which TGF-/3 stimulates locomotion and show that HA/RHAMM signalling is required for cell motility.
Materials and Methods

Cell Lines
The properties of the C1, C3, and C17.18 cell lines have been described previously (Samuel et al., 1992) . In brief, C1 and C3 were obtained when the parental 101"1/2 fibroblasts were transfected with a plasmid which contains the 6.6-kb fragment of T-24-H-ras and neo R gene. C17.18 was obtained when the parental C1 fibroblasts were transfected with pPK9A, which contained a complete TGF-Ot eDNA under the control of the metallothionein promoter. Furthermore, this eDNA was subjected to site-directed mntagenesis of cysteines 223 and 225 in the propeptide in order to allow for secretion of bioactive TGF-~I (Samuel et al., 1992) . All cell lines were maintained at 37°C on 150 nun plastic tissue culture plates (Falcon Plastics, Cockeysville, MD) in culture medium containing c~-MEM (Flow Laboratories, Mississanga, Ontario) supplemented with antibiotics and 10% (vol/vol) FCS (GIBCO BRL, Gaithersburg, MD). A serum-free medium called defined medium (DM) was also used which contained 4.0 ttg/ml transferrin and 2.0 /~g/ml insulin in c~-MEM.
Antibodies
Panspecific neutralizing anti-TGF-/~ antibody (R&D Systems, Inc., Minneapolis, MN) was used at a concentration of 500/~g/ml as suggested by the manufacturer. Monoclonal and polyclonal antibodies to RHAMM used in this study have been described previously (Turley and Torrance, 1985; Turley et al., 1987; Turley et al., 1991; Hardwick et al., 1992) . The antibodies include routine monoclonals MSV 10-4 and 10-6 that were raised against purified RHAMM protein, rabbit anti-RI-IAMM peptide aa266-2ss (R3.2), and rabbit anti-RHAMM fusion protein antibody all of which can block HA-mediated locomotion. Rabbit anti-RHAMM peptide aat24-145 antibody, which did not block locomotion, and normal murine IgG served as controls.
Northern Blotting
Cells were plated onto 150 mm tissue culture plates containing 10 ml c~-MEM (Flow Laboratories) supplemented with antibiotics and 10% (vol/vol) FBS (Hyclone Laboratories, Logan, UT). At ,'~90% confluence, cells were washed with Hanks medium and 2.0 ml of phosphate buffered 0.1% trypsin-EDTA solution was added. Cells were subsequently cultured in DM. At ~60% confluence, C3 cells were exogenously stimulated with TGF-~l (10 ng/ml) (R & D Systems, Inc.) or its secretion induced by the addition of zinc sulfate (100 ~tM) to cultures of C17.18. After appropriate incubation times, cells were washed with PBS (three times) and then removed with trypsin solution. A rapid RNA extraction method was used to prepare total cellular RNA (Gough, 1988) , which was subjected to electrophoresis through 1% formaldehyde-agarose gels followed by transfer to Nytran nylon membranes (Schleicher and Schuell, Keene, NH). Blots were prehybridized and hybridized as described previously (McClarty et ai., 1987; Hurta et al., 1990 , using a 32p-labeled 1.9-kb EcoRI fragment from the RHAMM cDNA containing plasmid DHI (Hardwick et al., 1992) . Blots were washed, and autoradingraphy was performed as previously described (Hurta et al., 1991) . Loading was monitored with a plasmid containing the glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) labeled by nick translation. Densitometric analysis of appropriate autoradiograms was carried out using a gel scanning spectrophotometer (DU-8; Beckman Instruments, Palo Alto, CA) and the one-dimensional Bio-Rad program (Bio-Rad Laboratories, Cambridge, MA).
Western Blot Assays
Western blot analyses were conducted using lysates of C3 and C17.18 fibroblasts prepared by treating cells with lysis buffer containing 25 mM Tris, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate, 0.15 M NaC1, I mM EDTA, and protease inhibitors (Turley et al., 1987) . Proteins were resolved on 10% SDS-PAGE gels (Laemmli, 1970) and transferred to nitrocellulose membranes at 175 V for 1 h at 15°C. The nitrocellulose was blocked by incubation for I h with 5% nonfat powdered milk in TBS (20 mM Tris, 130 mM NaCI, pH 7.4) and incubated with primary antibody (R3.2; 1:1,000 dilution in TBS containing 0.05% Tween-20 and 1% skim milk) for 12 h at 4°C on a gyratory shaker. The blot was then washed three times (10 rain) with TBS containing 0.05% Tween-20 (TTBS), incubated with HRPconjugated goat anti-rabbit IgG (1:5,000 in TTBS containing 1% skim milk) for 1 h, and then washed with TTBS. Blotting was visualized by the enhanced chemiluminescence (ECL) Western blotting detection system (Amersham, Mississauga, Ontario) foliowing manufacturers' directions. Quantitation was performed on a videodensitometer (model 620; Bio-Rad Laboratories).
Cellular Immunofluorescene and Flow Cytometry
C3 and C17.18 fibroblasts were cultured in 10% FCS and then switched to defined medium for between three and eight cell divisions before initiating treatment with either TGF-~I or ZnSO4. After stimulation for defined time periods, the cells were lifted from the petri dishes using 2.5 mM EDTA in HBSS and washed once with I-IBSS (GIBCO-BRL) containing 10% FCS. The viability of cells was determined by Trypan blue exclusion and was between 85 and 90%. An aliquot of 2 × 106 cells was then incubated with a 1/50 dilution of R3.2 antibody to peptide 268-288 encoded in the RHAMM eDNA (Hardwick et al., 1992) in a total volume of 200/~1 of HBSS/10% FCS for 30 min on ice. At the end of the incubation, the cells were washed once in cold HBSS/10% FCS and resuspended in a 1/100 dilution of fluorescein-conjugated goat anti-rabbit IgG antibody (Sigma Immunochemicals, St. Louis, MO) in the same buffer, incubated, and washed as above. The cells were then fixed in 400 ~tl of 1% paraformaldehyde in PBS and analyzed using an EPICS Model 753 flow cytometer (model 753; Epics, Inc., New York) (500 mW, 488 nm). Fluorescence was detected at 525 nm. Forward and 90 ° light scarer measurements were used to establish gates for intact, viable fibroblasts. Single parameter, 255 channel, log integral green fluorescent histograms were obtained, each based on 5 × 103 gated events.
Membrane immunofluorescence of C3 and C17.18 cells for photomicrography was performed as described in our earlier publications (Turley and Torrance, 1985; Tarley and Auersperg, 1989 ) using the R3.2 polyclonal antibody to peptide ~ts-2ss of RI-IAMM. Monolayers were fixed in freshly prepared 3 % paraformaldehyde for 10 min. Fixed monolayers were then incubated with antibody (1:40 dilution in PBS) overnight at 4°C. The monolayers were again washed then incubated with fluorescein-labeled goat anti-rabbit IgG (1:1,000 dilution in PBS). Processed monolayers were viewed with a Zeiss IM35 microscope (Carl Zeiss, Oberkochen, Germany) equipped with epifluorescence using nonoverlapping filters of 450--490 nm.
Quantification of Hyaluronan Secreted into Medium
Cell lines were cultured in 150 mm tissue culture plates (Falcon Laboratories) with DM at 37°C with or without TGF-~/I. At appropriate time intervals, this conditioned medium was removed, centrifuged to remove cell debris, placed in siliconized polypropylene tubes with protease inhibitors and then frozen at -80°C as described by Danielpour et al. (1988) . Conditioned medium obtained from above-mentioned cell lines was used to quantitate the amount of HA being secreted by C3 and C17.18 with or without TGFBl. This was done by using the Pharmacia HA Test (Pharmacia, Sweden) according to manufacturers' directions.
Antisense Oligonucleotides
Phosphorothioate oligodeoxynucleotides were prepared on a DNA synthesizer (380B; ABI Adv. Biotechnologies, Inc., Columbia, MD). Sequences used were as follows: TGF-/~] antisense, CGGA~TAC-GC_K~GC~A where only the sequence GGGCK;TACG used phosphorothioates and the remaining bases were phosphodiesters; TGF-/~ sense, GCCTCCCCCATGCGC~CCT where only the sequence CCCCCA'IGC used phosphorothioates. This mixture of phosphorothioates and phosphodiesters was the most effective and least toxic of the sequences that we evaluated. The oligonucleotides were added directly to subconfluent cells at the indicated times.
Peptides of the Hyaluronan Binding Domains
A peptide corresponding to one of the HA binding domains of RHAMM (Yang et al., 1993) was prepared on a peptide synthesizer (Applied Biosystems, Foster City, CA). The peptide from the second domain of RHAMM at amino acids 423-432 (KLRSQLVKRK) or randomized peptide '.23432 (QSKRLKKRVL) were added directly to subconfluent cells at a concentration of 10 ttg/ml in the presence or absence of TGF-~.
Results
Time (hours)
Induction of Locomotion by TGF-B,
The rate of locomotion of subconfluent C3 fibrosarcoma ceUs was determined by timelapse image analysis of random locomotion at increasing concentrations of TGF-B, in serumfree DM. We observed a maximal rate of C3 locomotion in the presence of TGF-B~ between 3 and 10 ng/ml (Fig. 1 A) , from 5 to 11 h after addition of TGF-~/~ to culture medium (Fig. 1 B) . At 30 ng/ml and higher, locomotion decreased ( Fig. 1 A) . No discernible increases in rates of locomotion over the controls were observed at the lower concentrations of TGF-/3, (0.1-0.5 ng/ml). Cells cultured in 10 ng/ml TGF-~ increased then decreased their motility rate with time after subculture so that locomotion had dropped to the rate of cells incubated without TGF-~/by 24 h, but not to the initial locomotion rate (Fig. 1 B) . Without added TGF-~/~, the motility rate increased progressively over 24 h to 26/~m/min or 2.4-fold over the rate measured within the first 2 h of plating the cells (Fig. 1 B) .
To determine whether TGF-~ could induce motility through autocrine stimulation, we also examined the C17.18 fibrosarcoma cells, which were transfected with an expression vector in which the complete coding region of TGF-~h was placed under the control of the metallothionein promoter (Samuel et al., 1992) . Cys 223 and 225 in the TGF-B~ propeptide had been converted to serines, mutations that result in dissociation of the propeptide and secretion of bioactive TGF-B] (Samuel et al., 1992) . After zinc sulphate 5 × 103 cells were placed onto a 25 cm 2 tissue culture flask (Falcon Laboratories) and cultured as described above. Cells were tracked 24-h after subculturing every 10 rain for 27 h and a minimum of 30 cells were examined in each experiment. (Samuel et al., 1992) . Image analysis of locomotion rates were recorded at time intervals following addition of 100 #M ZnSO4 or diluent to the culture medium of subconfluent cells.
(ZnSO4) treatment of C17.18, TGF-/3t mRNA was induced sixfold and bioactive TGF-/3 was increased 9-to ~ 14-fold (Samuel et al., 1992) . This cell line also became more motile after addition of ZnSO4 to subconfluent monolayers with increased locomotion detected as early as 2 h after TGF-/3~ induction. Motility rates reached maximal levels by 8-10 h (Fig. 1 C) .
R H A M M and Hyaluronan Synthesis Are Stimulated
by TGF-/3, It has previously been shown that TGF-/~t increased HA production (Toole et al., 1989 , Heldin et al., 1989 , and HA could itself mediate locomotion through an interaction with the HA receptor RHAMM (Turley, 1991) . We examined the regulation of RHAMM and HA by TGF-/3~ using subconfluent C3 cells cultured in defined medium in the presence or absence of TGF-/31. At designed time intervals, both mRNA and cell protein samples were prepared. Increased RHAMM mRNA levels were seen as early as 2 h after TGF-/3 stimulation (Fig. 2 A) . Total cellular RHAMM protein was elevated in cells exposed to 3 to 30 ng/ml TGF-/31 with maximal response occurring at a concentration of 10 ng/ml for 8 h (Fig. 2 B) , which was similar to the locomotory response to TGF-/31 (Fig. 1, A and B) . Over a 24-h time course, increased RHAMM protein expression was first detected 1 h after stimulation with TGF-/3t rising to near maximum levels by 4 h. A gradual but much smaller increase in RHAMM expression was also observed in C3 cells cultured without added TGF-/3~ reaching maximal expression at 24 h relative to controls at the initiation of the culture (Fig.  2 C) . Induction of TGF-/3~ secretion by ZnSO4 in C17.18 also resulted in an elevation in RHAMM mRNA expression (Fig. 3 A) for up to 8 h poststimulation which diminished somewhat at later times. RHAMM mRNA in uninduced C17.18 cells was essentially unchanged over 24 h of culture.
Corresponding changes in protein levels were detected in ZnSO4-induced cells, with maximal RHAMM expression fivefold over controls by 8-h postinduction (Fig. 3 B) . Increased RHAMM protein was detected on the cell surface by flow cytometry within 2 to 4 h after TGF-fll stimulation of C3 cells or ZnSO4 treatment of C17.18 cells using a polyclonal rabbit anti-RHAMM peptide 268-288 antibody and fluoresceinated goat anti-rabbit antibody (Fig. 4 A) . Peak expression was reached between 8 and 24 h, corresponding to the times noted for maximal production of RHAMM protein as detected by immunoblot assays (Figs.  2 C and 3 B) . Fluorescent photomicrography of cells stimulated for 8 h confirmed that most of the RHAMM protein was expressed at the cell surface (Fig. 4 B) .
C3 cells synthesized and released HA into the medium in large amounts when cultured in 10 ng/ml TGF-fl~. A transient increase in HA secretion in both TGF-fl~-treated cells and control was seen in the first 2 h of culture. However, the untreated control C3 cells gradually decreased secretion, while TGF-Brtreated cells continued to produce HA at a relatively stable level thereafter of about 1/~g/ml (Fig. 5 A) . Increased HA secretion by C17.18 was also observed after TGF-fl~ induction by ZnSO4 and remained higher than controis over the next 24 h (Fig. 5 B) .
Inhibition of CeU Motility with Anti-TGF-fl Antibody and Anti-Sense TGF-flt Oligonucleotides
C3 cells secrete increased amounts of bioactive TGF-fl~ (Schwarz et al., 1990) . The hypothesis that this secreted TGF-fl~ autostimulates locomotion was tested by treating C3 cells in subconfluent culture with a panspecific TGF-fl neutralizing antibody (500 ttg/ml). A 90% reduction in the rate of locomotion was observed within 5 h and then remained very low over the next 20 h (Fig. 6) / cells by anti-TGF-~1 antibodies. C3 cells were cultured in the presence of pan specific rabbit anti-TGF-tl antibody (500 tzg/ml) (4), or normal rabbit IgG (500 t~g/ml (m), and locomotion anal500 "1 lyzed over time.
1000
_. antisense oligonucleotides reduced TGF-~ secretion to / 1~/~ about 50% of sense and untreated controls (Fig. 7) , which was about equivalent to the inhibition of cell locomotion.
$" Inhibition of TGF-[31-lnduced Locomotion by "I-500 -~ ~ Anti-RHAMM Antibodies
We hypothesized that the TGF-/3~-induced locomotion was mediated through HA stimulation of the RHAMM receptor.
To test this directly, we used a panel of monoclonal anti- was also able to significantly decrease locomotion when it was added to cultures of C3 cells containing 3 ng/ml TGFfll (not shown).
To further test this hypothesis, an anti-sense TGF-/3~ oligonucleotide was synthesized based on the murine TGF-fl~ sequence spanning the initiation codon from -9 to +10 (see Materials and Methods). Either the antisense or sense oligonucleotide was added at a concentration of 0.8 #M to subconfluent C3 cells. A decrease in locomotion of 45% of sense or untreated controls was observed by 8 to 10 h (Fig.  7) . Examination of culture supernatants indicated that the (268-288) and anti-RHAMM fusion protein polyclonal antibody, which have been shown to inhibit HA-induced locomotion (Turley et al., 1991; Hardwick et al., 1992) . Antibody or normal IgG was added to subconfluent C3 cells after 8 h of stimulation with 10 ng/ml TGF-/% Before the addition of antibody, C3 locomotion progressively increased to an average velocity of 46.9 5= 1.9/~m/min. Within 30 min of the addition of 1/~g/ml of either RHAMM monoclonal or polyclonal antibodies, a reduction in the rates of locomotion to between 3.66 + 0.8 and 11.09 + 1.4 ftm/rnin (Fig. 8) was observed, with the polyclonal anti-RHAMM fusion protein antibody being the most effective. Controls included normal mouse IgG and polyclonal anti-RHAMM peptide 124-145 antibody, which do not block HA-induced locomotion (Hardwick et al., 1992) . Identical results were obtained when ZnSO4-stimulated C17.18 cells were treated with these antibodies (not shown).
We observed that C3 cells in culture in the absence of added TGF-/~ progressively increased locomotion (Fig. 1 A) as well as RHAMM protein expression (Fig. 2 C) . This increase may have been due to autocdne stimulation of RHAMM as a result of the ~nthesis and secretion of TGF- (CGGAGGGGGTACGGC-10 j+ CGGA) and sense (GCCTCC-.~ CCCATGCGGCCCT) oligo-5 ~ m nucleotide sequences were taken from the -9 to + 10 po-0 sitions spanning the initiation codon of TGF-flb Locomotion rate (+SE) was tracked by image analysis on 30 cells in each condition. Culture supematants from cells treated with oligonucleotides or culture medium for 24 h were collected and assayed for TGF-fl by the CCL64 bioassay (Khalil et al., 1989) . The TGF-fl levels were determined from four independent cultures in two experiments.
fl, by C3 cells (Schwartz et al., 1990) . This was tested by treating C3 cells, after 24 h in culture, with the anti-RHAMM fusion protein antibody in the absence of added TGF-fl~. Within 2 h of addition of antibody, the rate of locomotion decreased significantly from 24.5 + 3.1 to 7.5 -t-1.3 #m/min indicating that spontaneous locomotion of these cells could be blocked by an antibody that interferes with HA/RHAMM interaction.
Inhibition of TGF-fl-Induced and Spontaneous l~brosarcoma Motility by Peptide ~2~2 from the Hyaluronan-Binding Domain of RHAMM
RHAMM contains two discrete HA binding domains located near the carboxyl terminus characterized by clusters of basic amino acids (Yang et al., 1993) . Pcptides mimicking either of the two domains inhibit HA binding to RHAMM (Yang Monoclonal anti-RHAMM antibodies MSV 10-4 and MSV 10-6 are compared to normal murine IgG. Rabbit antibody to RHAMM peptide 26s-28s and anti-RHAMM fusion protein antibody, which have been shown to block HA-induced locomotion, were compared to anti-RHAMM peptidC 2.~45 polyclonal antibody that is inactive (Hardwick et al., 1992 (Hardwick et al., ). et al., 1993 . We have tested the hypothesis that peptide corresponding to amino acid 42a-432 of RHAMM will block TGF-fl~-induced and spontaneous motility of the C3 fibrosarcoma, presumably by interfering with the ability of HA to bind RHAMM. C3 cells were cultured, at subconfluence as described in Materials and Methods, in the presence or absence of 10 ng/ml of TGF-fl~. At the initiation of the culture, either peptide =~23-4a2, or scrambled peptide controls, was added at 10 #g/ml. Complete abrogation of TGF-fl~-induced cell migration by RHAMM binding domain peptide, but not the scrambled peptide, was observed over a tracking period of 8 h (Fig. 9 ). Spontaneous locomotion of C3 cells was also suppressed by the peptide mimicking the HA binding domain. Cell locomotion increased from 10.8/zm/min seen at the initiation of the culture to 28.3 #m/min after 24 h of culture and was inhibited to 14.7 #m/min by the RHAMM peptide (Fig. 9 ). The scrambled peptide had no effect on spontaneous tumor locomotion.
Discussion
The evidence presented supports the hypothesis that the participation of the HA receptor RHAMM is necessary for TGF-fll-mediated locomotion. The addition of TGF-fll to cell cultures, or induction of TGF-fll secretion, rapidly stimulated the synthesis of RHAMM message and protein, surface expression of RHAMM, HA synthesis, and cell locomotion. Antibodies that inhibited HA/RI-IAMM signalling and peptides that blocked HA binding to RHAMM prevented TGF-fll-induced increases in the rate of locomotion, and the spontaneous locomotion of these cells. Furthermore, blocking experiments with either neutralizing anti-TGF-fl antibody or antisense oligonucleotides to TGF-fll decreased cell locomotion indicating that TGF-fl~ was essential for spontaneous fibrosarcoma cell motility. From these data, we hypothesize that TGF-fl~-induced locomotion requires the participation of the HA receptor RHAMM. (Yang et al., 1993) , or the scrambled sequence Q-S-K-R-L-K-K-R-V-L (.) was added to the cultures at a concentration of 10 ~g/ml with the TGF-BI, and cell locomotion was analyzed every 2 h. (B) C3 cells were cultured in the absence of TGF-/3~. The cells were tracked for 2 h at the initiation of the culture (0 h) and between 22 and 24 h of culture (24 h). Then, either peptide (left) or scrambled peptide (right) was added to the culture and the motility rate analyzed for 2 h.
of fibroblasts transfected with a genomic clone of RHAMM. These cells showed both enhanced membrane expression of the receptor and an increased cell locomotion rate (Yang, B., G. Curpen, C. Wong, A. H. Greenberg, and E. A. Turley, manuscript submitted for publication).
The initial stimulation of motility by TGF-/3 was closely tied to increased levels of RHAMM mRNA and protein, and expression of RHAMM at the cell surface. Furthermore, a decrease in locomotion observed at TGF-/3, concentrations of 30 ng/ml or greater, was associated with lower RHAMM protein synthesis suggesting that down-regulation of cell motility was linked to the decreased availability of RHAMM. However, this may not be the only way in which locomotory responses to TGF-/~ can be down-regulated as a progressive decline in locomotion was observed after prolonged (>24 h) TGF-131 stimulation in the presence of stable or increasing RHAMM expression (Fig. 2 B) . The decline in locomotion rate may come from either rapid neutralization of TGF-~1 in tissue culture, or from other actions of TGF-~1 that may suppress cell movement.
TGF-jS, stimulates HA synthesis, and HA accumulates in the extending lamellae of locomoting tumor cells and can directly promote locomotion (Turley et al., 1991) . However, TGF-~ induces the synthesis of other proteoglycans including chondroitin/dermatan sulfate (Chert et al., 1987; Bassols and Massagu6, 1988) , heparan sulfate (Nugant et al., 1992) , as well as biglycan and versican (Kahari et al., 1991) . TGF-~ is inactivated by binding to the proteoglycan decorin (Yamaguchi et al., 1990) . Since TGF-~ reduces the synthesis of decorin in fibroblasts (ICAhari et al., 1991) it is unlikely that decorin is inactivating TGF4t, and modulating the locomotory response. Glycosaminoglycans such as chondroitin/ dermatan sulfate and heparan sulfate along with HA are important modulators of cellular recognition, adhesion, and motility (H66k et al., 1984) . The possibility therefore exists that proteoglycans induced by TGF-~, other than HA, participate in the locomotory response either indirectly by affecting adhesion, or directly by interfering with HA interaction with RHAMM. Recent data indicate that heparan sulfate binds with high affinity to the RHAMM receptor and effectively inhibits HA-binding and locomotion (Yang, B. , and E. A. Turley, manuscript submitted for publication) consistent with other reports that heparan sulphate inhibits cell motility (Klein-Soyer et al., 1989) . Thus, TGF-/3~ may ultimately downregulate motility by inducing heparan sulfate synthesis.
TGF-/3 also regulates the expression of the heterodimeric extracellular matrix integrin receptors (Heino et al., 1989) that have been implicated in the control of cell adhesion and locomotion (Hynes, 1992) . In fibroblasts and fibrosarcomas, as well as other cell types, TGF-/31 enhances the expression of the ~ integrin subunit and several a integrin subunits (Heino et al., 1989) . By substituting intracelhlar domains of different ot subunits, Chan et al. (1992) have recently shown that the a4 integrin was important for rhabdomyosarcoma cell migration. Migration on various extracellular matrices can be blocked by antibodies to the/~ subunit, while antibodies and peptides for different ot subunits blocked migration on certain types of matrix substrates (Yamada et al., 1990) . Because the integrin receptors are important in cellular interaction with extracellular matrix and in focal adhesion formation, TGF-/~-induced increases in expression likely effect locomotion, although this has not been demonstrated directly. How the RKAMM and integrin receptors might interact to achieve the coordinated responses of sequential adhesion and deadhesion that cells require to locomote is not known.
Although HA may promote locomotion by interacting with cell surface receptors (Toole, 1990; Turley, 1992) , it also binds to a number of proteins that are extracellular such as link protein (Goetinck et al., 1987; Nearne et al., 1986) , versican (Krusius et al., 1987) , hyaluronectin (Delpech and Halavent, 1981; Perides et al., 1989) , and aggrecan (Doege et al., 1987) . Once HA secretion is stimulated by TGF-/3, it may interact with the extracellular binding proteins that could enhance or inhibit its interaction with membrane receptor RHAMM. The other major HA-binding cell surface receptor is CD44. One isoform, CD44H, binds HA while the CD44E isoform does not (Culty et 
